Pengsheng Ding
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Vancomycin-stressed Staphylococcus aureus extracellular vesicles hijack macrophage autophagy to enhance bacterial intracellular survival.
Journal: Autophagy
Published: July 12, 2026
LukS-PV targeting C5aR inhibits EMT in hepatocellular carcinoma via the BCL6/HDAC6/HSPD1 axis.
Journal: Communications biology
Published: July 02, 2025
ARID1A deficiency promotes malignant proliferation of hepatocellular carcinoma by activating HDAC7/ENO1 signaling pathway.
Journal: Hepatology communications
Published: November 29, 2024
Toxin protein LukS-PV targeting complement receptor C5aR1 inhibits cell proliferation in hepatocellular carcinoma via the HDAC7-Wnt/β-catenin axis.
Journal: The Journal of biological chemistry
Published: July 18, 2024
LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.
Journal: BMC cancer
Published: December 27, 2021
LukS-PV inhibits the proliferation of hepatocellular carcinoma cells by maintaining FOXO3 stability via the PI3K/AKT signaling pathway.
Journal: Cellular signalling
Published: December 14, 2021
Erratum: LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression.
Journal: Molecular therapy oncolytics
Published: November 19, 2020
LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis.
Journal: OncoTargets and therapy
Published: August 24, 2020
LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression.
Journal: Molecular therapy oncolytics
Published: May 07, 2020
LukS-PV induces cell cycle arrest and apoptosis through p38/ERK MAPK signaling pathway in NSCLC cells.
Journal: Biochemical and biophysical research communications
Published: October 12, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026